GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 11.219
EU - Europa 6.727
NA - Nord America 6.451
SA - Sud America 766
AF - Africa 160
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.350
Nazione #
HK - Hong Kong 7.401
US - Stati Uniti d'America 6.309
FI - Finlandia 3.922
SG - Singapore 1.865
IT - Italia 724
CN - Cina 692
BR - Brasile 575
DE - Germania 562
VN - Vietnam 534
RU - Federazione Russa 448
ES - Italia 197
FR - Francia 165
IN - India 159
GB - Regno Unito 139
UA - Ucraina 128
IE - Irlanda 126
KR - Corea 111
TR - Turchia 94
AR - Argentina 86
CA - Canada 73
SE - Svezia 68
BD - Bangladesh 58
AT - Austria 55
JP - Giappone 53
NL - Olanda 47
ZA - Sudafrica 45
CZ - Repubblica Ceca 40
MX - Messico 40
PL - Polonia 40
ID - Indonesia 37
IQ - Iraq 37
EC - Ecuador 29
PK - Pakistan 25
ET - Etiopia 24
CO - Colombia 22
UZ - Uzbekistan 21
EG - Egitto 20
MA - Marocco 17
VE - Venezuela 17
MY - Malesia 16
SA - Arabia Saudita 16
PY - Paraguay 13
AU - Australia 12
CL - Cile 12
KE - Kenya 12
NP - Nepal 12
PH - Filippine 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
JO - Giordania 10
EU - Europa 8
AL - Albania 7
DZ - Algeria 7
HN - Honduras 7
KZ - Kazakistan 7
LT - Lituania 7
TH - Thailandia 7
BE - Belgio 6
PE - Perù 6
KG - Kirghizistan 5
MD - Moldavia 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
LY - Libia 4
MK - Macedonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
BJ - Benin 3
CR - Costa Rica 3
GE - Georgia 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
LU - Lussemburgo 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
HU - Ungheria 2
KH - Cambogia 2
LC - Santa Lucia 2
LV - Lettonia 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
Totale 25.324
Città #
Hong Kong 7.381
Helsinki 3.822
San Jose 951
Singapore 916
Dallas 596
Ashburn 564
Ann Arbor 465
Chandler 453
Munich 390
Woodbridge 326
Princeton 305
Wilmington 188
Council Bluffs 185
Houston 174
Beijing 161
Valencia 157
Jacksonville 149
Ho Chi Minh City 141
Lauterbourg 140
Naples 133
The Dalles 116
Los Angeles 114
Dong Ket 112
Dublin 110
Moscow 91
New York 89
Hanoi 87
Nuremberg 70
São Paulo 67
Salerno 66
Orem 62
Santa Clara 60
Izmir 58
Andover 57
Rome 48
Boardman 43
Turku 43
Tokyo 39
Brno 36
Chennai 36
Warsaw 36
Nanjing 35
Redwood City 35
Washington 34
Brooklyn 33
Frankfurt am Main 31
Johannesburg 31
Stockholm 31
Amsterdam 30
Milan 30
Montreal 29
Rio de Janeiro 27
London 26
Manchester 26
Addis Ababa 24
Atlanta 24
Fisciano 24
Phoenix 24
Pune 24
Pellezzano 23
Denver 22
Seattle 22
Vienna 22
Changsha 18
Chicago 18
Düsseldorf 18
Fairfield 18
Haiphong 18
Jyväskylä 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Boston 16
Brasília 16
Columbus 16
Poplar 16
Toronto 16
Da Nang 15
Hải Dương 15
Seoul 15
Curitiba 14
Norwalk 14
Mumbai 13
Tianjin 13
Ankara 12
Buffalo 12
Dhaka 12
Lahore 12
Lappeenranta 12
Mexico City 12
Nanchang 12
Quito 12
Guangzhou 11
San Francisco 11
West Jordan 11
Cairo 10
City of London 10
Jakarta 10
Medellín 10
Nairobi 10
Totale 20.158
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.032
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.982
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 891
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 711
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 653
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 494
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 482
Aplastic anemia: Pathophysiology 482
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 470
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 418
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 359
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 356
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 340
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 328
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 326
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 323
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 310
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 297
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 284
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 248
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 247
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 223
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 221
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 218
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 217
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 197
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 191
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 191
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 190
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 190
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 180
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 174
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 169
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 164
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 163
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 162
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 158
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 155
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 153
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 152
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 148
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 144
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 141
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 141
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 137
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 135
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 132
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 132
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 131
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 131
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 131
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 131
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 128
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study 125
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 124
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 124
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 122
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 119
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 119
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 118
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 117
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 117
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 115
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 114
Stem cell and macrophage roles in skeletal muscle regenerative medicine 114
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 114
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 112
Endocrine disorders after autologous and allogeneic stem cell transplantation 109
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 106
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 106
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 102
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 102
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 100
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 99
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 99
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 98
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 98
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 97
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 95
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 94
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 93
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 93
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 92
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 92
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 92
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 91
OPSI threat in hematological patients 91
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 87
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 86
A case series of blastic plasmacytoid dendritic cell neoplasia 86
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 85
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 83
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 83
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 83
COVID-19 vaccine-associated lymphadenopathy: a review 83
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 83
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 83
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 80
Can we turn off the “Covid-biting-tail” inflammation? 80
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome 80
Totale 21.948
Categoria #
all - tutte 66.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 0 0 0 0 0 58 138
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/202618.148 1.420 3.933 3.465 739 1.158 474 1.320 277 4.389 920 53 0
Totale 25.649